Addison’s Disease*

Of 957 patients with type 1 diabetes without known Addison's disease 1.6% (n = 15) were positive for 21-hydroxylase autoantibodies. Among DQ8/DQ2 heterozygous patients, the percentage expressing 21-hydroxylase autoantibodies was 5% (10 of 208) vs. less than 0.5% of patients with neither DQ8 nor DQ2. Three of the diabetic patients found to have 21-hydroxylase autoantibodies on screening were subsequently diagnosed with Addison's disease. Overall, the genotype DQ8/DQ2, consisting of DRB1*0404/DQ8 with DRB1*0301/DQ2, was present in 14 of 21 patients with Addison's disease (8 of 12 with diabetes and 6 of 9 without diabetes or antiislet autoantibodies) vs. 0.7% of the general population (109 of 15,547; P < 10(-6)) and 11% of patients with DM without Addison's disease (62 of 578; P < 10(-6)). Among patients with diabetes with DQ8, Addison's disease was strongly associated with the specific DRB1 subtype, DRB1*0404 (8 of 9 patients from 8 families, in contrast to only 109 of 408 DQ8 DM patients with diabetes without Addison's disease having DRB1*0404; P < 0.001). Among 21-hydroxylase autoantibody-positive DQ8 patients, 80% with DRB1*0404 (12 of 15) had Addison's disease, in contrast to 1 of 10 autoantibody-positive patients with DRB1*0401 or DRB1*0402 (P < 0.001). We conclude that patients with DRB1*0404 and 21-hydroxylase autoantibodies are at high risk for Addison's disease. Patients with DRB1*0401 and DRB1*0402 have more limited progression to Addison's disease despite the presence of 21-hydroxylase autoantibodies.

[1]  L. Peltonen,et al.  An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains , 1997, Nature Genetics.

[2]  G. Eisenbarth,et al.  Screening patients with insulin-dependent diabetes mellitus for adrenal insufficiency. , 1997, The New England journal of medicine.

[3]  C. Betterle,et al.  Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay. , 1997, The Journal of clinical endocrinology and metabolism.

[4]  E. Toussirot,et al.  Molecular mechanisms involved in the association of HLA-DR4 and rheumatoid arthritis , 1997, Immunologic research.

[5]  H. Luthman,et al.  21‐hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease , 1997, Clinical and experimental immunology.

[6]  J. Ilonen,et al.  Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. , 1997, Clinical immunology and immunopathology.

[7]  M. Boscaro,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society I. Adrenal Cortex and Steroid 21-Hydroxylase Autoantibodies in Adult Patients with Organ-Specific Autoimmune Diseases: Markers of Low Progression , 2022 .

[8]  G. Eisenbarth,et al.  Molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes. , 1996, Biochemical and biophysical research communications.

[9]  H. Chase,et al.  Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies , 1996, Diabetes.

[10]  N. Maclaren,et al.  Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity. , 1996, The Journal of clinical endocrinology and metabolism.

[11]  G. Eisenbarth,et al.  Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele. , 1996, Journal of autoimmunity.

[12]  T. Lybrand,et al.  A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis. , 1996, Journal of autoimmunity.

[13]  Y. Li,et al.  Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. , 1996, The Journal of clinical investigation.

[14]  Å. Lernmark,et al.  High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. , 1995, The Journal of clinical endocrinology and metabolism.

[15]  K. Usadel,et al.  Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. , 1995, The Journal of clinical endocrinology and metabolism.

[16]  H. Erlich,et al.  HLA-DQB1*0602 Is Associated With Dominant Protection From Diabetes Even Among Islet Cell Antibody–Positive First-Degree Relatives of Patients with IDDM , 1995, Diabetes.

[17]  C. Betterle,et al.  Immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in autoimmune adrenal diseases. , 1995, Clinical chemistry.

[18]  S. Kominami,et al.  Autoimmune Addison's disease--evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency. , 1994, The Journal of clinical endocrinology and metabolism.

[19]  J. Partanen,et al.  Major histocompatibility complex class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility. , 1994, Human immunology.

[20]  R. Uibo,et al.  Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. , 1994, The Journal of clinical endocrinology and metabolism.

[21]  R. E. Rowe,et al.  High Genetic Risk for IDDM in the Pacific Northwest: First Report From the Washington State Diabetes Prediction Study , 1994, Diabetes.

[22]  L. Peltonen,et al.  An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21 , 1994, Nature Genetics.

[23]  J. Furmaniak,et al.  Autoimmune Addison's disease , 1993, FEBS letters.

[24]  Henry A. Erlich,et al.  HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families , 1993, Nature Genetics.

[25]  M. Kocova,et al.  Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers. , 1992, American journal of epidemiology.

[26]  J. Craft,et al.  Steroid 21‐hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease , 1992, FEBS letters.

[27]  O. Kämpe,et al.  21-hydroxylase, a major autoantigen in idiopathic Addison's disease , 1992, The Lancet.

[28]  D. U. Rabin,et al.  Cloning and Expression of IDDM-Specific Human Autoantigens , 1992, Diabetes.

[29]  R. Klein,et al.  HLA-DR and the 5' insulin gene polymorphism in insulin-dependent diabetes. , 1991, Metabolism: clinical and experimental.

[30]  J. Bach.  Insulin-dependent diabetes mellitus. , 1991, Current opinion in immunology.

[31]  B. Boehm,et al.  The HLA-DQβ non-Asp-57 allele: a predictor of future insulin-dependent diabetes mellitus in patients with autoimmune Addison's disease , 1991 .

[32]  B. Boehm,et al.  The HLA-DQ beta non-Asp-57 allele: a predictor of future insulin-dependent diabetes mellitus in patients with autoimmune Addison's disease. , 1991, Tissue antigens.

[33]  J. Perheentupa,et al.  Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. , 1990, The New England journal of medicine.

[34]  S. Baekkeskov,et al.  Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase , 1990, Nature.

[35]  B. Czarnocka,et al.  Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases , 1985, FEBS letters.

[36]  R. Campbell,et al.  Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[37]  N. Maclaren,et al.  Two Types of Autoimmune Addison's Disease Associated with Different Polyglandular Autoimmune (PGA) Syndromes , 1981, Medicine.

[38]  G. Eisenbarth,et al.  HLA type and occurrence of disease in familial polyglandular failure. , 1978, The New England journal of medicine.

[39]  J. N. Morris,et al.  Epidemiological and clinical picture of Addison's disease. , 1968, Lancet.